Phase 3 Breathlessness Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Reducing Breathlessness With Dronabinol in COPD Patients
COPDBreathlessnessCannabis
Vejle Hospital30 enrolled1 locationNCT06473701
Recruiting
Phase 3
Does blocking the body's own morphine-like chemicals during exercise change the perception of breathlessness?
Breathlessness during exercise in people with Chronic Obstructive Pulmonary Disease.
Flinders University- Deptment of Palliative and Supportive Services30 enrolled1 locationACTRN12611001182987
Withdrawn
Phase 3
A single arm, open label pilot study of low dose regular opioids with low dose regular benzodiazepines for the relief of refractory breathlessness.
Refractory breathlessness
Flinders University10 enrolled3 locationsACTRN12610000589088
Terminated
Phase 3
Midazolam Nasal Spray for the treatment of breathlessness in patients with life-limiting disease
Dyspnoea (Breathlessness)
Arohanui Hospice Service Trust, Clare Randall as representative200 enrolled3 locationsACTRN12609000506291